Wezlana™ (ustekinumab-auub) – New first-time interchangeable biosimilar approval
October 31, 2023 - The FDA announced the approval of Amgen’s Wezlana (ustekinumab-auub), biosimilar and interchangeable to Janssen’s Stelara® (ustekinumab).
Download PDF
